It has come to my attention that recently constituents have been faced with the stock shortage of hormone replacement therapy (HRT) medication at local pharmacies. I recognise the impact this can have on people’s well-being, as the symptoms of perimenopause can indeed be challenging. Women make up 51% of the population and should not be an afterthought in healthcare. Ensuring access to essential medications is a fundamental aspect of our healthcare system, and it is concerning when individuals face difficulties.
In an effort to better understand these challenges, I recently met with Sarah Turner, the founder of www.motherland.fun, a platform dedicated to raising awareness about perimenopause. It's an invaluable resource offering support to those going through this phase of life. Our conversation touched on various aspects of perimenopause including the complexities of managing symptoms, the lack of information available on the topic, and highlighted a need for more resources and knowledge sharing in this area. This meeting was a reminder of the importance of addressing and supporting women's health issues, and the role platforms like www.motherland.fun play in these efforts.
On a positive note, I am pleased to report significant progress in making HRT more accessible and affordable. Since April of last year, half a million women in England have benefited from more affordable HRT through Prescription Prepayment Certificates (PPCs), reducing annual costs to just £19.30. This initiative, part of the Women’s Health Strategy, has saved women over £11 million in 9 months and made HRT more accessible.
To specifically address the HRT supply issues, the Department of Health and Social Care’s medicine supply team is working closely with suppliers to ensure a steady supply and to tackle any shortages. Though most of the 70+ HRT products are available, increased demand has led to some shortages. In response, the Government has established an HRT Supply Taskforce to manage stock and increase supply. Additionally, Serious Shortage Protocols (SSPs) have been implemented, allowing pharmacists to provide alternative HRT products without a prescription in certain cases. These measures have been effective in managing dispensing and offering alternatives, with two SSPs currently in place. I encourage you to stay updated on HRT supply by visiting www.sps.nhs.uk.
Furthermore, the Government's investment of £25 million in establishing women’s health hubs, these hubs will improve access to care, enhance health outcomes, and reduce health inequalities for women. By establishing at least one women’s health hub in every local area this year, it aims to ensure better access and quality of care in services for menstrual problems, contraception, pelvic pain, menopause care, and more.
I can assure you that women's health remains a priority, and I will continue to advocate for improvements and accessibility in healthcare.
